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Abstract
Src family non-receptor tyrosine kinases play a prominent role in multiple cellular process-
es, including: cell proliferation, differentiation, cell survival, stress response, and cell adhe-
sion and migration, among others. And when deregulated by mutations, overexpression,
and/or the arrival of faulty incoming signals, its hyperactivity contributes to the development
of hematological and solid tumors. c-Src is a prototypical member of this family of kinases,
which is highly regulated by a set of phosphorylation events. Other factor contributing to the
regulation of Src activity appears to be mediated by the Ca2+ signal generated in cells by dif-
ferent effectors, where the Ca2+-receptor protein calmodulin (CaM) plays a key role. In this
report we demonstrate that CaM directly interacts with Src in both Ca2+-dependent and Ca2
+-independent manners in vitro and in living cells, and that the CaM antagonist N-(6-amino-
hexyl)-5-chloro-1-naphthalenesulfonamide (W-7) inhibits the activation of this kinase in-
duced by the upstream activation of the epidermal growth factor receptor (EGFR), in human
carcinoma epidermoide A431 cells, and by hydrogen peroxide-induced oxidative stress, in
both A431 cells and human breast adenocarcinoma SK-BR-3 cells. Furthermore, we show
that the Ca2+/CaM complex strongly activates the auto-phosphorylation and tyrosine kinase
activity of c-Src toward exogenous substrates, but most relevantly and for the first time, we
demonstrate that Ca2+-free CaM (apo-CaM) exerts a far higher activatory action on Src
auto-phosphorylation and kinase activity toward exogenous substrates than the one ex-
erted by the Ca2+/CaM complex. This suggests that a transient increase in the cytosolic
concentration of free Ca2+ is not an absolute requirement for CaM-mediated activation of
Src in living cells, and that a direct regulation of Src by apo-CaM could be inferred.
PLOS ONE | DOI:10.1371/journal.pone.0128783 June 9, 2015 1 / 16
a11111
OPEN ACCESS
Citation: Stateva SR, Salas V, Anguita E, Benaim G,
Villalobo A (2015) Ca2+/Calmodulin and Apo-
Calmodulin Both Bind to and Enhance the Tyrosine
Kinase Activity of c-Src. PLoS ONE 10(6): e0128783.
doi:10.1371/journal.pone.0128783
Academic Editor: Laszlo Buday, Hungarian
Academy of Sciences, HUNGARY
Received: March 11, 2015
Accepted: April 30, 2015
Published: June 9, 2015
Copyright: © 2015 Stateva et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All data are included
within the manuscript.
Funding: This work was funded by grants to AV from
the Secretaría de Estado de Investigación, Desarrollo
e Innovación (SAF2011-23494 & SAF2014-52048-R),
the Consejería de Educación de la Comunidad de
Madrid (S2011/BMD-2349), the CSIC program i-
COOP+ 2014 (COOPA20053), and the European
Commission (contract PITN-GA-2011-289033). SRS
received funding from the People Program (Marie
Curie Actions) of the European Union's Seventh
Framework Program FP7/2007-2013 under REA
grant agreement n° PITN-GA-2011-289033. VS and
Introduction
Calmodulin (CaM) is a versatile Ca2+ receptor protein present in all so far tested eukaryotic
cells that binds to and modulates the function of hundreds of proteins with or without enzy-
matic activity, exerting therefore multiple physiological roles in the cell (reviewed in [1]). Thus,
CaM couples the Ca2+ signal generated by multiple effectors (e.g. hormones and growth fac-
tors) to appropriate cellular responses. Nevertheless, its Ca2+-free form (apo-CaM) also binds
to and regulates a variety of target proteins (reviewed in [2]). A diversity of mechanisms for the
interaction of CaM with many of their targets has been described (reviewed in [3–5]). Albeit
there is not an universal consensus sequence, CaM binding sites present in target proteins are
classified either as amphipathic basic α-helical domains with conserved bulky hydrophobic res-
idues at positions 1-(5)-10, 1-(8)-14 or 1–16; IQ motifs with the general sequence (FILV)Qxxx
(RK)Gxxx(RK)xx(FILVWY), where x represents any amino acid; or IQ-like motifs with the
general sequence (FILV)Qxxx(RK)xxxxxxxx [6–10].
Among the multiple physiological functions of CaM, its role in the control of a variety of sys-
tems implicated in cell proliferation and other important cellular processes relevant for the biol-
ogy of tumor cells, such as programmed cell death and autophagy, has been amply studied
(reviewed in [11]). Our group has been studying the action of CaM on the control of receptor ty-
rosine kinases (RTKs) implicated in cell proliferation. Among these, important mediators in the
proliferative response of cells are the erythroblastic leukemia viral oncogene homologue (ErbB)
family members (ErbB1/EGFR/HER1, ErbB2/HER2/neu, ErbB3/HER3 and ErbB4/HER4) that
play a prominent role in cancerogenesis. We demonstrated the Ca2+-dependent interaction of
CaM with the cytosolic juxtamembrane segment (residues 645–660) of the epidermal growth
factor receptor (EGFR) and its action in contributing to the ligand-dependent activation of the
receptor [12–14]. This occurs most likely by a mechanism proposed by McLaughlin and collab-
orators [15], in which Ca2+/CaM helps to release the auto-inhibition of the ligand-free EGFR
mediated by the electrostatic interaction of the positively charged CaM-binding site (and part of
the tyrosine kinase domain) with the negatively charged inner leaflet of the plasma membrane.
Likewise, we also demonstrated a Ca2+-dependent binding of CaM to ErbB2 and its regulatory
effects on the activation of the receptor and downstream signaling pathways [16]. Other RTKs
are also known to bind CaM, including: the insulin receptor, where CaM regulates its activity
[17]; and TrkA, where CaM appears to control its proteolytic processing [18].
Non-receptor tyrosine kinases belonging to the Src family also play prominent roles in pro-
liferation and cancerogenesis (reviewed in [19]). Several members of the Src kinase family are
known to phosphorylate CaM (reviewed in [20]), underscoring that CaM interacts with the
catalytic site of these kinases. In addition to this, and most importantly, CaM interacts with
some regulatory site(s) present in Src. Thus, an earlier report demonstrated that a myristoy-
lated peptide corresponding to the N-terminal of v-Src interacts with the Ca2+/CaM complex,
while the non-myristoylated peptide was not able to do so [21]. Also, it has been proposed that
upon Ca2+ entry in effector-stimulated cells, CaM residing in lipid rafts interacts in a Ca2+-de-
pendent manner with and activates c-Src, and in turn c-Src phosphorylates and inhibits protein
phosphatase 2A (PP2A), preventing in this manner its inhibitory action on Akt and henceforth
promoting melanoma tumor growth [22]. The activation of c-Src by Ca
2+
/CaM was also dem-
onstrated in transfected neuroblastoma cells overexpressing α-synuclein, a cytotoxic protein
abundant in Lewy bodies in Parkinson’s disease, by a mechanism also implicating PP2A [23].
The direct interaction of CaM with a recombinant glutathione S-transferase (GST)-Src fusion
protein was demonstrated to occur via a dual Ca2+-dependent and Ca2+-independent mecha-
nism, although mutation of the proposed CaM-binding site located at the Src homology do-
main 2 (SH2) of c-Src only partially prevented CaM binding [24]. Interestingly, Src was shown
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to co-immunoprecipitate with CaM but not with tyrosine-phosphorylated CaM in keratino-
cytes [25]. Also, the unique and SH3 domains of c-Src has been shown to bind acidic lipids,
usually present in the inner leaflet of the plasma membrane, and binding of Ca2+/CaM to the
unique domain has been proposed to regulate this process [26].
Nevertheless, these reports did not fully clarify the actual mechanism by which CaM inter-
acts and activates c-Src, or if this process always occurs in the cell in a Ca2+-dependent manner.
This highlights the need for additional work to determine whether CaM controls the tyrosine
kinase activity of c-Src in both Ca2+-dependent and/or Ca2+-independent manners. In this re-
port we demonstrated, using an in vitro assay system and in living tumor cells, that CaM direct-
ly binds to c-Src in both Ca2+-dependent and Ca2+-independent manners, and that Ca2+/CaM
and apo-CaM both enhances the tyrosine kinase activity of c-Src.
Materials and Methods
Reagents
Radiolabelled [γ-32P]ATP (triethylammonium salt) (3,000 Ci/mmol) (1 Ci = 37 GBq), Hyper-
film-MP x-ray films, calmodulin-Sepharose 4B, and the enhanced chemiluminescence (ECL)
kits were obtained from GE Healthcare-Amersham. The Pierce Classic Magnetic IP/Co-IP kit
was obtained from Thermo Scientific. ATP (sodium salt), L-glutamic acid and L-tyrosine poly-
mer (poly-L-(Glu:Tyr)) (4:1), Sepharore 4B, rabbit polyclonal anti-phospho-Src (Y418) (recog-
nizing human phospho-Y416), and anti-mouse (Fc specific) immunoglobulin G (IgG)
polyclonal (goat) antibody coupled to horseradish peroxidase were purchased from Sigma-Al-
drich. The polyvinylidene difluoride (PVDF) membranes were obtained from Pall Corpora-
tion. Rabbit monoclonal anti-Src (human) (clone 36D10, isotype IgG), rabbit polyclonal anti-
phospho-Src family (Y416) and rabbit monoclonal anti-glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) (clone 14C10, isotype IgG) antibodies were obtained from Cell Signaling Co.
Goat anti-rabbit IgG (H+L) polyclonal antibody coupled to horseradish peroxidase was from
Life Technologies. Mouse monoclonal anti-phospho-tyrosine antibody (clone 4G10, isotype
IgG2bκ), and active (763 U/mg) purified 6His-tagged full-length recombinant human c-Src ex-
pressed by baculovirus in Sf21 insect cells were purchased fromMillipore. One unit of Src ac-
tivity corresponds to the incorporation of 1 nmol of phosphate into 250 μM cdc2 substrate
peptide per min at 30°C using 100 μMATP according to the manufacture’s datasheet.
Cell culture
Human epidermoid carcinoma A431 cells (ATCC CRL-1555) and human breast adenocarci-
noma SK-BR-3 cells (ATCC HTB-30) were obtained from the American Type Culture Collec-
tion (ATCC), and grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% (v/v) fetal bovine serum (FBS), 2 mM L-glutamine and 40 μg/ml gentamicin at 37°C in an
humidified air atmosphere containing 5% CO2.
Expression and purification of calmodulin
The expression and purification of wild type CaM, CaM(Y99D/Y138D) and CaM(Y99E/
Y138E) from transformed Escherichia coli BL21(DE3)pLysS was done using protocols previ-
ously described [27, 28].
Preparation of the cell membrane fraction
A431 cells were washed with PBS (137 mMNaCl, 2.7 mM KCl, 12 mM Na/K-phosphate, pH
7.4), gently scraped from the plates, harvested by centrifugation, and lysed by mechanical
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disruption using a homogenizer in 3 ml of an ice-cold hypotonic buffer containing 15 mM
Hepes-Na (pH 7.4), 1 mM ethylene glycol-bis(2-aminoethylether)-N,N,N0,N0-tetraacetic acid
(EGTA), and a cocktail of protease inhibitors containing: 0.5 mM 4-(2-aminoethyl) benzene-
sulfonyl fluoride (AEBSF), 0.4 μM aprotinin, 25 μM bestatin, 7.5 μM [1-[N-[(L-3-trans-carbox-
yoxirane-2-carbonyl)-L-leucyl]amino]-4-guanidinobutane] (E-64), 10 μM leupeptin, 5 μM
pepstatin A, and freshly prepared 0.6 mM phenylmethylsulfonyl fluoride (PMSF). The lysate
was incubated 10 min on ice and centrifuged at 130,000 g for 30 min at 4°C. The supernatant
was discarded, and the pellet resuspended in the same buffer and centrifuged as above. This
pellet, that corresponds to the membrane fraction, was washed with the same buffer but with-
out EGTA, centrifuged again, resuspended in 3 ml of 25 mMHepes-Na (pH 7.4) containing
the protease inhibitors and stored at -80°C for later use.
Polyacrylamide gel electrophoresis andWestern blot
Proteins were separated by polyacrylamide gel electrophoresis in the presence of sodium dode-
cyl sulfate (SDS-PAGE) in a 5–20% (w/v) linear gradient slab gel of polyacrylamide and 0.1%
(w/v) sodium dodecyl sulfate (pH 8.3) at 6–10 mA overnight [29]. The proteins were electro-
transferred from the gels to PVDF or nitrocellulose membranes for 2 h at 300 mA in a medium
containing 48 mM Tris-base, 36.6 mM L-glycine, 0.04% (w/v) sodium dodecyl sulfate (SDS),
and 20% (v/v) methanol. In the case of CaM, a nitrocellulose membrane instead of PVDF
membrane was regularly used. The proteins were fixed with 0.2% (v/v) glutaraldehyde in 25
mM Tris-HCl (pH 8), 150 mMNaCl and 2.7 mM KCl (TNK buffer) for 45 min, and transiently
stained with Fast Green to ascertain the regularity of the transfer procedure. The PVDF mem-
branes were blocked with 5% (w/v) bovine serum albumin or 3–5% (w/v) fat-free powdered
milk, following the instructions of the antibodies' manufacturers, in 0.1% (w/v) Tween-20, 100
mM Tris-HCl (pH 8.8), 500 mMNaCl and 0.25 mM KCl (T-TBS buffer); and probed overnight
at 4°C using a 1/2000 dilution of the corresponding primary antibody, and for 1 h at room tem-
perature using a 1/5000 dilution of the appropriate secondary anti-IgG antibody coupled to
horseradish peroxidase. The bands were visualized upon development with ECL, following in-
structions from the manufacturer, and exposure of x-ray films for appropriate periods of time.
The intensity of the bands was quantified using the ImageJ 1.46r program (National Institutes
of Health, USA).
Isolation of Src by CaM-affinity chromatography and immobilized-CaM
pull-down
Cell membrane-anchored Src from A431 cells was detached from the membrane fraction upon
incubation with 1% (w/v) Triton X-100 and 5% (w/v) glycerol at 0°C for 10 min. The sample
was centrifuged at 130,000 g for 30 min and the supernatant was used to isolate Src by CaM-af-
finity chromatography or pull-down using immobilized CaM. The isolation of Src by Ca2+-de-
pendent CaM-affinity chromatography was carried out loading the solubilized membrane
fraction in a small column (1–2 ml bed volume) of CaM-Sepharose 4B equilibrated with a buff-
er containing 25 mMHepes-NaOH (pH 7.4), 1% (w/v) Triton X-100, 5% (w/v) glycerol, 0.1
mM CaCl2, and the protease inhibitors cocktail described above (Ca2+-buffer). The column was
washed with 25 volumes of the Ca2+-buffer, and Src was eluted using the same buffer but con-
taining 1 mM EGTA instead of CaCl2 (EGTA-buffer). Proteins in the eluted fractions (0.6 ml)
were precipitated with 10% (w/v) trichloroacetic acid and processed by SDS-PAGE andWest-
ern blot for Src identification. The pull-down of Src was done using a slurry of CaM-Sepharose
4B beads (200 μl) in a buffer containing 25 mMNa-Hepes (pH 7.4), 1% (w/v) Triton X-100
and 5% (w/v) glycerol supplemented either with 0.1 mM CaCl2 or 1 mM EGTA. We used
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naked Sepharose 4B beads as negative binding control. The beads were washed 10 times with
the corresponding Ca2+ or EGTA buffers before processing the samples by SDS-PAGE and
Western blot for Src identification as described above.
Co-immunoprecipitation of CaM with Src
Immunoprecipitation of Src from a detergent-solubilized cell extract of A431 cells (2 mg pro-
tein) was performed using the Pierce Classic Magnetic IP/Co-IP kit, an anti-Src antibody and
protein-A/G following the manufacture instructions. The samples were processed for
SDS-PAGE and Western blot using anti-CaM and anti-Src antibodies as described above.
Src phosphorylation assay
The auto-phosphorylation of recombinant c-Src (0.1 μg) was assayed at 37°C in a medium con-
taining 15 mM Tris-HCl (pH 7.5), 5 mMMgCl2, 1 mM dithiothreitol, 1 mM EGTA, 1.2 mM
CaCl2 (when added), and 2.3 μMwild type CaM, or the phospho-mimetic CaM(Y99D/Y138D)
and CaM(Y99E/Y138E) mutants, when added. The reaction was started upon addition of 2
mM ATP and stopped by the addition of Laemmli buffer and boiled for 5 min. The samples
were subjected to Western blot and probed with an anti-phospho-tyrosine antibody or an anti-
phospho-Y416-Src specific antibody to detect active phosphorylated Src, and an anti-Src
(total) antibody and/or GAPDH antibody as loading controls. The phosphorylation of the arti-
ficial exogenous substrate poly-L-(Glu-Tyr) (0.1 mg/ml) by recombinant c-Src (1 unit) was car-
ried out at 37°C during 15 min in a medium containing 15 mMHepes-NaOH (pH 7.4), 5 mM
MgCl2, 1 mM dithiothreitol, 1 mM EGTA, 1.1 mM CaCl2 (when added) and 4 μMCaM (when
added) using 10 μM (2 μCi) [γ-32P]ATP as substrate. The 32P-labeled poly-L-(Glu-Tyr) and
32P-labeled c-Src were visualized by autoradiography.
Src activation assays in living cells
In the case of A431 cells, Src was activated either upon ligand-dependent activation of the
EGFR, as an upstream signaling component of c-Src [30], adding 10 nM epidermal growth fac-
tor (EGF) during 2 min or upon induction of oxidative stress by adding 1 mMH2O2 for 15 min,
as described [31, 32]. In the case of SK-BR-3 cells, upon induction of oxidative stress by adding
1 mMH2O2 for 15 min, as above. The reaction was arrested upon addition of ice-cold 1% (w/v)
trichloroacetic acid, and the samples were processed by SDS-PAGE andWestern blot. The
PVDF membranes were probed with anti-phospho-tyrosine or anti-phospho-Y416-Src specific
antibodies to detect active phosphorylated Src, anti-phospho-tyrosine to detect activated EGFR,
and anti-Src (total), anti-EGFR (total) and/or anti-GAPDH antibodies as loading controls.
Statistical analysis
Two-tailed Student’s t test was performed using the Microsoft Excel (Microsoft Co., Redmon,
WA) or GraphPad Prism (GraphPad Software Inc., La Jolla, CA) software programs. Data
were expressed as the mean ± SEM and differences were considered significant at p 0.05 as
indicated in the legends to the figures.
Results
Ca2+-dependent and Ca2+-independent interaction of CaM with Src
We first performed Ca2+-dependent CaM-affinity chromatography of a detergent-solubilized
membrane fraction from A431 tumor cells in order to determine whether Src binds CaM in a
Ca2+-dependent manner. Fig 1A shows that indeed at least a fraction of the Src loaded in the
Src Activation by Ca2+/CaM and Apo-CaM
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Fig 1. Calmodulin directly interacts with Src in the absence and presence of Ca2+. (A) Ca2+-dependent calmodulin-affinity chromatography of Src
solubilized from the membrane fraction of A431 cells was performed as described in Materials and Methods. The material loaded in the CaM-Sepharose
column (input), the last fraction after washing with the Ca2+-buffer (Ca2+-wash), and the EGTA-eluted fractions were analyzed byWestern blot using an anti-
Src antibody. (B) Pull-down of Src solubilized from a membrane fraction of A431 cells was performed in the absence (-) and presence (+) of Ca2+ using
CaM-Sepharose (CaM-beads) as described in Materials and Methods. Naked Sepharose 4B beads were used as negative binding control. The presence of
bound Src to the beads was analyzed byWestern blot using an anti-Src antibody. (C) Src was solubilized from a membrane fraction of A431 cells (2 mg
protein) and immunoprecipitated (IP) using an anti-Src antibody as described in Materials and Methods. The immunocomplex was processed byWestern
blot using anti-CaM and anti-Src antibodies. Non-relevant rabbit IgG (~22 μg) was used as a negative control (mock IP).
doi:10.1371/journal.pone.0128783.g001
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CaM-Sepharose column in the presence of Ca2+ can be eluted with a buffer containing the Ca2
+-chelating agent EGTA. As this technique does not show whether part of Src remained bound
to CaM-Sepharose in the absence of Ca2+ (presence of EGTA), we performed pull-down exper-
iments using immobilized CaM in the absence and presence of Ca2+. Fig 1B shows that Src
binds to CaM covalently conjugated to the Sepharose beads, both in the presence of Ca2+ and
its absence (presence of EGTA), while no significant binding of Src was detected using CaM-
free naked beads. Furthermore, we demonstrated that CaM co-immunoprecipitated with Src
solubilized from A431 cells (Fig 1C). Overall, these experiments show direct interaction be-
tween CaM and Src and that this interaction occurs by both Ca2+-dependent and Ca2+-inde-
pendent mechanisms, in agreement with previous findings [24].
The calmodulin antagonist W-7 inhibits Src activation in living cells
Ligand-dependent activation of EGFR results in the down-stream activation of Src [30]. To de-
termine whether CaM is implicated in EGFR-mediated Src activation in EGFR-overexpressing
A431 cells, we performed experiments in the presence of the CaM antagonist N-(6-amino-
hexyl)-5-chloro-1-naphthalenesulfonamide (W-7) and the less potent but not inactive inhibi-
tor N-(4-aminobutyl)-2-naphthalenesulfonamide (W-12). Fig 2A (left and center panels), 2B
and 2D show that activation of the EGFR by its ligand EGF also results in Src phosphorylation
at Y416 (activation) as expected, and that increasing concentrations of W-7 progressively in-
hibit both phosphorylation processes. In contrast, high concentration (50 μM) of W-12, a chlo-
rine-free analogue of W-7 with far lower affinity for CaM (IC50 of 260 μM versus 28 μM,
respectively, inhibiting Ca2+/CaM-dependent phosphodiesterase) [33, 34], has a much lower
inhibitory effects on EGFR activation than on Src activation (Fig 2D). We have previously
demonstrated that in living cells the Ca2+/CaM complex aided the ligand-dependent activation
of the EGFR, and that W-7 inhibits this process [12–14]. Nevertheless, as the inhibitory action
of W-7 on Src phosphorylation (activation) was significantly stronger than that observed on li-
gand-dependent EGFR auto(trans)phosphorylation, this suggests a direct activatory effect of
CaM on Src. Furthermore, we demonstrated that W-7 not only inhibits the ligand-dependent
phosphorylation (activation) of EGFR but the ligand-dependent tyrosine-phosphorylation of
many downstream proteins (not shown).
Yet, the results discussed above do not represent a clear-cut evidence for a direct action of
CaM on Src activation in living cells. Therefore, we searched for another way to activate Src
without the involvement of EGFR to test the possible inhibitory effect of W-7. Fig 2A (right
panel), 2C and 2E show that hydrogen peroxide, a known activator of Src [31, 32], strongly en-
hances Src auto-phosphorylation (activation) in A431 cells as expected, and that W-7 indeed
significantly inhibits this process in contrast to the lower effect of the low-affinity CaM inhibi-
tor W-12 at identical concentrations (Fig 2E). Moreover, hydrogen peroxide strongly activated
the EGFR, a process that was inhibited by the Src inhibitor PP1 (not shown), suggesting that
this was a consequence of EGFR phosphorylation by Src, as this process has been extensively
documented [35–39], and it is known that H2O2 induces EGFR transactivation by a Src-medi-
ated mechanism [40].
We also tested the inhibitory action of W-7 on hydrogen peroxide-dependent activation of
Src in a different cell line. Fig 3A and 3B show that hydrogen peroxide enhances the phosphor-
ylation (activation) of Src in SK-BR-3 cells, and that the CaM antagonist W-7 inhibits the hy-
drogen peroxide-dependent activation of Src while W-12 does not. As W-7 appears to inhibit
CaM in its Ca2+-bound form [41] and may not affect apo-CaM, these results clearly suggest
that Ca2+/CaM regulates Src activity in living cells, although no information can be extracted
from these experiments on the potential control that apo-CaMmay exert on Src activation.
Src Activation by Ca2+/CaM and Apo-CaM
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Fig 2. W-7 inhibits EGFR- and H2O2-mediated Src activation in A431 cells. (A) A431 cells were incubated
in the absence (-) and presence (+) of the indicated concentrations of W-12 or W-7 during 15 min. Thereafter,
the cells were stimulated either with 10 nM EGF for 2 min or 1 mMH2O2 for 15 min. The reaction was arrested
and subjected to Western blot analysis as described in Materials and Methods, and probed with anti-
phospho-tyrosine (4G10), anti-phospho-Src (Y416), and anti-EGFR (total), anti-Src (total) and anti-GAPDH
antibodies as loading controls. (B, C) The plots present the mean ± SEM EGF-dependent (n = 6) and H2O2-
dependent (n = 3) activation of Src at increasing concentrations of W-7 from experiments similar to those
shown in A. (D, E) The plots present the mean ± SEM EGF-dependent (n = 6) and H2O2-dependent (n = 3)
activation of Src in the absence (None) and presence of 50 μMW-12 or 50 μMW-7 from experiments similar
to those shown in A. Statistically significant differences with p < 0.05 (*), p < 0.005 (**) and p < 0.0001 (***)
using the Student’s t-test are indicated.
doi:10.1371/journal.pone.0128783.g002
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Fig 3. W-7 inhibits H2O2-mediated Src activation in SK-BR-3 cells. (A) SK-BR-3 cells were incubated in
the absence (-) and presence (+) of the indicated concentrations of W-12 or W-7 during 15 min. Thereafter,
the cells were stimulated with 1 mMH2O2 for 15 min. The reaction was arrested and subjected to Western
blot analysis as described in Materials and Methods, and probed with anti-phospho-Src (Y416), and anti-Src
(total) and anti-GAPDH antibodies as loading controls. (B) The plot presents the mean ± SEM (n = 5) H2O2-
dependent activation of Src in the absence (None) and presence of either 50 μMW-12 or 50 μMW-7 from
experiments similar to those shown in A. Statistically significant differences with p < 0.05 (*) using the
Student’s t-test are indicated.
doi:10.1371/journal.pone.0128783.g003
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Both Ca2+/CaM and apo-CaM activate Src
Significant evidence has been obtained on the activatory action of Ca2+/CaM on the tyrosine
kinase activity of Src [22–24]. However, it was assumed that this process is always preceded by
the generation of a Ca2+ signal upon cell activation by a variety of effectors required for the for-
mation of the Ca2+/CaM complex. Little is known, however, on the possible action of apo-CaM
on the activation of Src. To solve this question, we tested the effect of CaM on the auto-phos-
phorylation (activation) of human c-Src in the absence and presence of Ca2+ using a full-length
recombinant protein. We ascertained that the recombinant c-Src used was indeed full-length
without truncation of the N-terminal, as the commercial supplier provided the sequence, the
purification of the protein was performed using the 6His-tag located in the N-terminal, and the
molecular mass perfectly matched the expected 60 kDa in SDS-PAGE. Fig 4A and 4B show
that little auto-phosphorylation of c-Src was observed in the absence of CaM and that the pres-
ence of this modulator strongly enhances its auto-phosphorylation in both conditions. The ac-
tivation of c-Src was significantly stronger in the absence of Ca2+ (presence of EGTA) than in
its presence. And surprisingly, this effect was also observed when the residual basal activity of
c-Src was assayed in the absence of CaM. This suggests a direct inhibitory action of calcium ion
on the kinase.
To ascertain that the activatory action of CaM on Src was not limited to its auto-phosphory-
lation, but also enhances its tyrosine kinase activity toward exogenous substrates, we tested the
phosphorylation of the artificial substrate poly-L-(Glu:Tyr). Fig 4C and 4D show that indeed
the phosphorylation of poly-L-(Glu:Tyr) by recombinant Src was strongly enhanced by the
presence of CaM, both in the absence and presence of Ca2+. And again it was in the former
condition when CaM exerted its maximum action on Src activation.
As CaM is known to be phosphorylated by different Src family kinases (reviewed in [20]),
we tested the action of phospho-(Y)-mimetic CaMmutants, on the auto-phosphorylation (ac-
tivation) of recombinant c-Src. Fig 5A–5C show little, if any, significant differences in the acti-
vatory action of wild type CaM versus CaM(Y99D/Y138D) both in the absence and presence of
Ca2+. Moreover, both CaM(Y99D/Y138D) and CaM(Y99E/Y138E) had the capacity to activate
c-Src more strongly in the absence of Ca2+ (presence of EGTA) than in its presence (Fig 5D–
5F). This effect was similar to the one exerted by wild type CaM (see Fig 2A and 2B).
Discussion
In this report we show that Src not only binds CaM in the absence and presence of Ca2+, as oth-
ers have previously demonstrated [24], but that the Ca2+/CaM complex, and more efficiently
apo-CaM, both enhance the auto-phosphorylation and catalytic activity of Src toward exoge-
nous substrates. Although the activation of Src by different signals appears to require Ca2+, as
demonstrated by the attenuation of Src activation in cells loaded with the Ca2+-chelator
[1,2-bis(2-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid tetrakis(acetoxymethyl ester)]
(BAPTA-AM) [42, 43], the Ca2+-independent action of CaM on Src activation advises for a
partial revision of previous findings on the necessary involvement of an executor Ca2+ signal
preceding the binding of CaM to Src [22, 23, 42, 43]. The drastic reduction of the cytosolic con-
centration of free Ca2+ imposed in BAPTA-loaded cells may also affect Ca2+/CaM-dependent
systems upstream of Src, as for example the EGFR [12–14], and not exclusively Src activation.
Therefore, a transient Ca2+ rise may not be an obligatory step to attain activation of Src since
apo-CaM exerts this role even more effectively than Ca2+/CaM. One possibility, however,
could be that oscillations in the cytosolic concentration of free Ca2+ indeed could act as a rate
modulator of the activity of the Src/CaM complex, where CaM could be already tethered to
Src, as it occurs in other CaM-binding proteins such as distinct Ca2+-channels [44]. Thus, the
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kinase activity in the Src/CaM complex could decrease when the concentration of Ca2+ rises,
by occupying the Ca2+-binding sites of tethered CaM, and conversely increases when the con-
centration of Ca2+ falls and the cation is released from CaM. These events may not necessarily
be a simple two-stage cycle (Ca2+-free and Ca2+-bound steps), as CaM has two high-affinity
and two low-affinity Ca2+-binding sites [1]. Thus, this process may occur as a multi-stage cycle
where a variable number of Ca2+-binding sites are free or occupied at a given time, what may
result in a variable rate of Src activity and a more fine-tuned regulation of the kinase.
An alternative possibility is that distinct Ca2+-dependent and Ca2+-independent CaM-bind-
ing sites could exist in Src. Yuan and collaborators [24] proposed as the CaM-binding site of
human Src the sequence 203KHYKIRKLDSGGF215 (residues 204–214 in the GST-tagged pro-
tein), located in the terminal part of the SH2 domain. However, mutation of this site substitut-
ing the sequence KHYKIRKLDS by alanine residues only partially prevented CaM binding
[24]. This suggests the existence of additional CaM-binding sites in Src. We identified in silico
in human c-Src two additional potential CaM-binding sites, that we denote atypical IQ-like
Fig 4. Apo-calmodulin and Ca2+/calmodulin both activate c-Src. (A) The auto-phosphorylation assay of recombinant c-Src was performed in the absence
and presence of CaM and in the absence and presence of Ca2+ for the indicated time as described in Materials and Methods. The samples were subjected to
Western blot and probed with an anti-phospho-tyrosine antibody. Duplicate samples were probed with an anti-Src (total) antibody as loading control. (B) The
plot presents the mean ± range c-Src phosphorylation in the absence (None) and presence of CaM, and in the absence (EGTA) and presence of Ca2+ from
two independent experiments similar to the one shown in A. (C) Phosphorylation of poly-L-(Glu:Tyr) by recombinant c-Src was performed using [γ-32P]ATP
as substrate as described in Material and Methods. [32P]-labeled c-Src (arrow) and [32P]-labeled poly-L-(Glu:Tyr) (bracket) are indicated. (D) The plot
presents the mean ± SEM poly-L-(Glu:Tyr) phosphorylation in the absence and presence of 4 μMCaM and 100 μMCaCl2 (Ca
2+) from three independent
experiments similar to the one shown in C.
doi:10.1371/journal.pone.0128783.g004
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Fig 5. Phospho-(Y)-mimetic CaMmutants also activate c-Src. (A) Auto-phosphorylation assays of
recombinant c-Src (0.1 μg) was performed in a medium containing 15 mM Tris-HCl (pH 7.5), 5 mMMgCl2, 1
mM dithiothreitol, 1 mM EGTA and where indicated 1.2 mMCaCl2 (200 μM free Ca
2+) in the presence of
either wild type CaM or CaM(Y99D/Y138D) in a total volume of 100 μl. The samples were processed for
SDS-PAGE andWestern blot using anti-phospho-tyrosine and anti-Src antibodies as described in Materials
and Methods. (B, C) The plots present the mean ± SEM (n = 2) c-Src phosphorylation in the presence of wild
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motifs, corresponding to the sequences: 146IQAEEWYFGKITR158, located in the proximal re-
gion of the SH2 domain, and 311LQEAQVMKKLR321, located in the proximal region of the ty-
rosine kinase domain. These sites may contribute to the binding of apo-CaM, as many IQ- and
related IQ-like motifs are known to be receptor sites for Ca2+-free CaM in different target pro-
teins [2, 6].
The CaM antagonist W-7 is known to interact with phospholipids. In fact, we have demon-
strated that both W-7/W-13 efficiently prevent the binding of a peptide corresponding to the
CaM-BD of EGFR (residues 645–660) to lipid vesicles [45]. This opens the possibility that the
action of W-7 on Src activity could be mediated at least in part by disturbing the known inter-
action of the unique domain of the kinase with the inner leaflet of the plasma membrane [26].
We have observed that W-7 slightly increases in a biphasic manner the basal activity of Src in
non-stimulated cells (Fig 2B and 2C), similar to what we observed with W-13 activating the
EGFR in the absence of ligand [45]. However, the inhibitory effect of W-7 on Src activation in-
duced by EGF or H2O2 addition indicates that this effect is mainly due to CaM inhibition. W-7
has been widely used in living cells to antagonize CaM and the effects that this inhibition exerts
in a variety of CaM-dependent systems. Nevertheless, we cannot exclude off-target direct effect
of W-7 on c-Src in living cells, as well as in all experimental systems so far studies. Particularly,
when this CaM antagonist has been shown to inhibit Ca2+-dependent protein kinase and to a
lesser extent cAMP/cGMP-dependent protein kinases [46].
The non-receptor tyrosine kinase Src is subjected to complex regulatory mechanisms medi-
ated by phosphorylation events that control its activation status [19, 47–49]. The stabilization
of its activation loop induced by auto-phosphorylation of Y416 maintains the kinase in an
open conformation, allowing substrate binding and hence subsequent signal transmission by
the resulting phosphorylated substrates [48]. On the other hand, the specific phosphorylation
of its C-terminal tail at Y527 by C-terminal Src kinase (Csk), maintains Src in a closed confor-
mation repressing its activity [47]. The identification of Src as a CaM-binding protein, and the
proposed location of the CaM-binding site(s) at the SH2 and/or tyrosine kinase domains, sug-
gests that CaMmay mediate its action maintaining Src in its open activated conformation.
We also observed that Ca2+ per se (absence of CaM) has a direct inhibitory action on Src
auto-phosphorylation. This is unlikely to be mediated by an exogenous Ca2+-dependent sys-
tem, as for example protein kinase C (PKC), because we used a purified preparation of recom-
binant Src and the assay was devoid of cofactors required for PKC activation. Although
speculative, an interesting possibility is to search for potential EF-hand Ca2+-binding pocket(s)
in Src.
Src-family kinases including c-Src are known to phosphorylate CaM (reviewed in [20]) as
also demonstrated by us [27, 28]. It has been shown in keratinocytes that phospho-(Y138)-
CaM does not co-immunoprecipitate with Src, while non-phosphorylated CaM does [25]. Our
results using CaM(Y99D/Y138D) and CaM(Y99E/Y138E) suggest that diphospho-(Y99/
Y138)-CaMmay be able to interact with Src, in contrast to what it was reported with mono-
phospho-(Y138)-CaM [25]. No information, however, is available on the possible action of
type CaM or CaM(Y99D/Y138D) in the absence and presence of free Ca2+ from experiments similar to the
ones shown in A. (D) Auto-phosphorylation assays of recombinant c-Src (0.1 μg) was performed in a medium
containing 15 mM Tris-HCl (pH 7.5), 5 mMMgCl2, 1 mM dithiothreitol, 1 mM EGTA and where indicated 1.2
mMCaCl2 (200 μM free Ca
2+) in the absence or presence of either CaM(Y99D/Y138D) or CaM(Y99E/Y138E)
in a total volume of 100 μl. The samples were processed for SDS-PAGE andWestern blot using anti-
phospho-tyrosine and anti-Src antibodies as described in Materials and Methods (E, F). The plots present the
mean ± SEM c-Src phosphorylation in the presence of CaM(Y99D/Y138D) (n = 1) or CaM(Y99E/Y138E)
(n = 2), and in the absence and presence of free Ca2+ from experiments similar to the ones shown in A.
doi:10.1371/journal.pone.0128783.g005
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distinct phospho-(Tyr)-CaM species on Src activity. Nevertheless, the effect of distinct phos-
phorylated tyrosine residues and/or variable phosphorylation stoichiometry in the regulation
of Src should be investigated, as the importance of these parameters has been demonstrated in
other CaM-dependent systems (reviewed in [20]).
Another point of interest is the fact that the two partners in the well-known bidirectional
activatory trans-phosphorylation between EGFR and Src, where Src phosphorylates the EGFR
[35–39], and the EGFR phosphorylates Src [30], are regulated by CaM, albeit in different man-
ners. The regulation of EGFR by CaM is a Ca2+-dependent process [12–14], while the regula-
tion of Src by CaM appears to be a two-faced process, Ca2+-dependent and Ca2+-independent
(this work). This opens the door to explore in future work how physiological oscillations in the
cytosolic concentration of free Ca2+, upon cell stimulation by mitogenic and/or other factors,
modifies this mechanism by affecting in different manner both interconnected partners, the
EGFR and Src, and hence the proliferative response.
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